Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.000 | 100.200 | 0.200 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 8.632 | 11.077 |
Price to Book | 1.040 | 1.426 |
Price to Sales | 0.659 | 0.904 |
Price to Cash Flow | 4.887 | 6.046 |
Dividend Yield | 5.644 | 4.274 |
5 Years Earnings Growth | 8.296 | 10.538 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 31.400 | 20.331 |
Energy | 11.740 | 7.792 |
Industrials | 10.580 | 15.637 |
Consumer Cyclical | 10.340 | 8.979 |
Consumer Defensive | 9.240 | 9.607 |
Healthcare | 7.630 | 13.724 |
Basic Materials | 7.580 | 6.920 |
Utilities | 5.190 | 4.350 |
Communication Services | 5.120 | 6.399 |
Technology | 1.180 | 5.614 |
Number of long holdings: 110
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 4.64 | 31.61 | +0.25% | |
HSBC | GB0005405286 | 3.83 | 724.40 | -0.34% | |
TotalEnergies SE | FR0000120271 | 3.50 | 57.09 | -0.16% | |
Santander | ES0113900J37 | 2.75 | 4.3680 | -3.53% | |
UniCredit | IT0005239360 | 2.22 | 38.090 | -1.88% | |
Mercedes Benz Group | DE0007100000 | 2.20 | 52.270 | +0.81% | |
Novartis | CH0012005267 | 2.17 | 93.68 | +2.32% | |
Allianz | DE0008404005 | 2.15 | 291.40 | +0.10% | |
ING Groep | NL0011821202 | 1.97 | 14.65 | -1.15% | |
BNP Paribas | FR0000131104 | 1.95 | 56.92 | -2.23% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MEAG EuroInvest I | 16.86M | 11.60 | 4.96 | 8.06 | ||
MEAG EuroErtrag | 456.64M | 5.10 | 0.28 | 2.17 | ||
MEAG ProInvest | 380.59M | 11.19 | 3.25 | 6.98 | ||
MEAG GlobalBalance DF | 81.47M | 8.14 | 0.48 | 4.32 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review